National Research Corporation (NASDAQ:NRCI) today announced
results for the first quarter 2011.
- Quarterly revenue up 14% to $19.8
million
- Quarterly net income up 10% to $3.5
million
- Quarterly diluted earnings per share of
$0.51, up 9%
- Total Contract Value reaches $76.6
million, up 24%
Commenting on the first quarter results, Michael D. Hays,
president and chief executive officer of National Research
Corporation, said, “Against a strong comparable quarter in 2010,
our first quarter of 2011 was very rewarding and set a number of
records. We continue to achieve large increases in new sales as a
result of the compelling value proposition of our
subscription-based offerings, supported by investments made to
expand our sales force. Our sales growth is also attributed to the
Company’s unique position with a clear differentiated portfolio
that directly meets the industry need, driven by healthcare reform,
for cross-continuum expertise.
Revenue for the quarter ended March 31, 2011, was $19.8 million,
compared to $17.4 million for the same quarter in 2010. Net income
for the quarter ended March 31, 2011, was $3.5 million, or $.52 per
basic and $.51 per diluted share, compared to $3.1 million for the
first quarter 2010, or $0.47 per basic and diluted share.
In closing, Patrick E. Beans, chief financial officer of
National Research Corporation, said, “As evidenced by our sales
traction, subscription-based offerings are finding great market
acceptance, even though such contracts often push revenue to
outlying periods.”
A listen-only simulcast of National Research Corporation’s 2011
first quarter conference call will be available online at
www.earnings.com on May 4, 2011, beginning at 11:00 a.m. Eastern
time. The online replay will follow approximately one hour later
and continue for 30 days.
National Research Corporation, headquartered in Lincoln,
Nebraska, is a leading provider of performance measurement,
improvement services, and governance education to the healthcare
industry in the United States and Canada.
This press release includes “forward-looking” statements related
to the Company that can generally be identified as describing the
Company’s future plans, objectives or goals. Such forward-looking
statements are subject to risks and uncertainties that could cause
actual results or outcomes to differ materially from those
currently anticipated. These forward-looking statements are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. For further information about the
factors that could affect the Company’s future results, please see
the Company’s filings with the Securities and Exchange
Commission.
NATIONAL RESEARCH CORPORATION
Unaudited Consolidated Statements of
Operations
(In thousands, except per share data)
Three Months Ended
March 31,
2011
2010
Revenue $ 19,791 $ 17,370 Operating expenses:
Direct expenses 6,758 6,456 Selling, general and administrative
6,090 4,469 Depreciation and amortization 1,243
1,098 Total operating expenses 14,091
12,023 Operating income 5,700 5,347
Other income (expense), net: Interest income 2 1 Interest expense
(169 ) (98 ) Other, net (29 ) (43 ) Total
other income (expense), net (196 ) (140 )
Income before income taxes 5,504 5,207 Provision for income taxes
2,048 2,079 Net income $ 3,456
$ 3,128 Net income per share, basic $ 0.52 $
0.47 Net income per share, diluted $ 0.51 $ 0.47
Weighted average shares outstanding: Basic 6,654 6,640
Diluted 6,809 6,711
NATIONAL RESEARCH CORPORATION
Unaudited Consolidated Condensed
Balance Sheets
(Dollars in thousands)
March. 31,
Dec. 31,
2011
2010
ASSETS Current Assets: Cash and cash equivalents $ 3,316 $
3,519 Accounts receivable, net 12,925 9,172 Income taxes
recoverable 713 1,277 Other current assets 3,432
3,373 Total current assets 20,386 17,341 Net property and
equipment 14,227 14,482 Other, net 63,595 63,947
Total Assets $ 98,208 $ 95,770 LIABILITIES AND
SHAREHOLDERS’ EQUITY Current Liabilities: Accounts payable
and accrued expenses $ 2,599 $ 3,872 Deferred revenue 18,759 17,701
Accrued compensation 2,526 2,750 Notes payable 1,843
1,827 Total current liabilities 25,727 26,150 Non-current
liabilities 21,345 21,036 Total Liabilities
47,072 47,186 Shareholders’ Equity: Common
stock, $0.001 par value; 20,000,000 shares authorized; issued
8,091,985 in 2011 and 8,044,855 in 2010; outstanding 6,713,407 in
2011 and 6,668,574 in 2010 8 8 Additional paid-in capital 29,392
28,970 Retained earnings 43,322 41,343 Accumulated other
comprehensive income 1,333 1,108 Treasury stock (22,919 )
(22,845 ) Total shareholders’ equity 51,136
48,584 Total liabilities and shareholders’ equity $ 98,208 $ 95,770
National Research Corp. (MM) (NASDAQ:NRCI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
National Research Corp. (MM) (NASDAQ:NRCI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024